Supporting Sample Test Resolution and Regulatory Operations for a Hormone Drug in China

End-to-end

Regulatory operations support throughout the review process

Effective

coordination with NMPA testing institutes and stakeholders

Proactive

issue resolution to minimize Regulatory delays

Client Overview

A South Korea–China-based biopharmaceutical company required specialized Regulatory Affairs and Regulatory Operations support in China for a hormone drug undergoing the Regulatory review and approval process. The client sought expert assistance in addressing sample testing challenges, managing Health Authority interactions, coordinating stakeholder communication, and ensuring compliance with evolving NMPA pharmaceutical registration requirements.

Background

As part of its China market access strategy, the client was progressing a hormone drug through the Regulatory review process when challenges arose during sample testing activities. The issue had the potential to impact Regulatory timelines, delay product approval, and disrupt commercialization plans.

Given the complexity of China's pharmaceutical Regulatory environment and the importance of timely issue resolution, the client required an experienced Regulatory partner capable of coordinating with NMPA testing centers, managing Regulatory communications, and supporting operational activities to maintain submission momentum and compliance.

Services in Scope

Sample Testing Resolution and Coordination

Regulatory Operations Management

NMPA Communication and Query Management

Stakeholder Coordination and Project Management

Regulatory Documentation Review and Support

Health Authority Engagement Support

Compliance Risk Assessment and Mitigation

Market Authorization and Registration Support

Challenge

Sample Testing Issues During Regulatory Review The client encountered challenges related to sample testing requirements that required immediate resolution to avoid disruptions to the product review process.

Tight Regulatory Timelines Delays in addressing testing-related concerns could have impacted approval timelines and market entry plans for the hormone drug.

Complex Stakeholder Coordination Managing communication between testing institutes, Regulatory authorities, and internal project teams required strong Regulatory project management and operational oversight.

Evolving NMPA Expectations Ensuring alignment with China's evolving Regulatory requirements and technical expectations was critical to maintaining submission progress and Regulatory compliance.

Solution

Sample Test Resolution Support

Worked closely with testing institutes and relevant stakeholders to investigate, address, and resolve sample testing concerns in a timely manner.

NMPA Communication Management

Facilitated proactive communication with NMPA-related stakeholders to ensure clarity, alignment, and efficient issue resolution throughout the review process.

Regulatory Operations Oversight

Provided end-to-end Regulatory operations support to manage project timelines, track milestones, and maintain submission readiness.

Risk Identification and Mitigation

Assessed potential Regulatory risks and implemented mitigation strategies to minimize the likelihood of delays or compliance challenges.

Cross-Functional Stakeholder Coordination

Coordinated activities across global and local teams to ensure seamless execution of Regulatory and operational activities.

Impact

Freyr's support enabled the client to successfully resolve sample testing challenges while maintaining Regulatory momentum and compliance throughout the review process.